| Literature DB >> 19742222 |
V P Paralikar, M M Agashe, S B Sarmukaddam, H N Dabholkar, D Gosoniu, M G Weiss.
Abstract
CONTEXT: Disorders of unexplained fatigue are researched globally and debated prominently concerning their biomedical and psychiatric comorbidity. Such studies are needed in India. AIMS: To identify biomedical markers and psychiatric morbidity of disorders of severe unexplained fatigue or weakness with disability, designated neurasthenia spectrum disorders (NSDs). To compare biomedical markers of patients with controls. To study correlation between biomedical markers and psychiatric morbidity. SETTINGS: Four specialty outpatient clinics of Psychiatry, Medicine, Dermatology, and Ayurved of an urban general hospital.Entities:
Keywords: Anthropometry; anxiety disorders; malnutrition; neurasthenia; somatoform disorders
Year: 2008 PMID: 19742222 PMCID: PMC2738343 DOI: 10.4103/0019-5545.42394
Source DB: PubMed Journal: Indian J Psychiatry ISSN: 0019-5545 Impact factor: 1.759
Sexwise distribution of hemoglobin levels (g/dl), BMI & CAMA (sq cm) for patients with NSDs and controls
| Biometric parameter | Sex | Psychiatry | Medicine | Dermatology | Ayurved | Total | Controls | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | ||||||||||
| Male | 38 | 12.75 | 12 | 11.83 | 41 | 12.54 | 26 | 13.53 | 117 | 12.76 | 20 | 11.75 | |||
| Female | 39 | 10.5 | 82 | 10.45 | 37 | 10.76 | 51 | 11.51 | 209 | 10.77 | 14 | 10.71 | 0.9811 | ||
| Both | 77 | 11.61 | 94 | 10.62 | 78 | 11.69 | 77 | 12.2 | 326 | 11.49 | 34 | 11.32 | 0.8244 | ||
| 11.31 | 10.94 | 11.4 | 12.23 | 11.53 | 11.11 | ||||||||||
| Male | 40 | 21.18 | 12 | 19.55 | 43 | 20.01 | 23 | 19.99 | 0.5997 | 118 | 20.36 | 20 | 21.06 | 0.2273 | |
| Female | 40 | 23.03 | 80 | 21.7 | 36 | 23.37 | 41 | 21.12 | 0.1724 | 197 | 22.15 | 17 | 22.93 | 0.3572 | |
| Both | 80 | 22.1 | 92 | 21.42 | 79 | 21.54 | 64 | 20.72 | 0.3111 | 315 | 21.48 | 37 | 21.92 | 0.2688 | |
| 22.34 | 20.89 | 22.14 | 20.7 | 21.45 | 22.20 | ||||||||||
| Male | 40 | 33.22 | 12 | 29.98 | 40 | 28.61 | 23 | 37.02 | 0.3846 | 115 | 32.04 | 20 | 39.03 | ||
| Female | 39 | 28.47 | 79 | 18.61 | 35 | 27.37 | 40 | 29.84 | 193 | 24.52 | 17 | 39.94 | |||
| Both | 79 | 30.86 | 91 | 20.11 | 75 | 28.04 | 63 | 32.46 | 308 | 27.33 | 37 | 39.45 | |||
| 30.34 | 23.08 | 27.86 | 32.66 | 27.46 | 39.58 | ||||||||||
Kruskall-Wallis test.
Mann-Whitney test, SD values expressed in italics, Significant P values expressed in bold
Sexwise distribution of mean difference in Hemoglobin levels (gm%), BMI & CAMA (sq cm) in patients with NSDs and controls
| Variable | Sex | Psychiatry | Medicine | Dermatology | Ayurved | ||||
|---|---|---|---|---|---|---|---|---|---|
| Mean difference | Mean difference | Mean difference | Mean difference | ||||||
| Hb | Male | 1.000 | 0.080 | 0.981 | 0.790 | 1.780 | |||
| Female | -0.214 | 0.888 | -0.264 | 0.756 | 0.046 | 1.000 | 0.796 | 0.071 | |
| Both | 0.290 | 0.570 | -0.700 | 0.059 | 0.370 | 0.390 | 0.880 | ||
| BMI | Male | 0.120 | 0.999 | -1.510 | 0.477 | -1.050 | 0.535 | -1.070 | 0.618 |
| Female | 0.100 | 1.000 | -1.230 | 0.646 | 0.440 | 0.988 | -1.810 | 0.413 | |
| Both | 0.180 | 0.995 | -0.500 | 0.925 | -0.380 | 0.975 | -1.200 | 0.429 | |
| CAMA | Male | -5.810 | 0.309 | -9.050 | 0.179 | -10.420 | 0.014 | -2.010 | 0.976 |
| Female | -11.470 | -21.330 | -12.570 | 0.005 | -10.100 | ||||
| Both | -8.590 | -19.340 | -11.410 | -6.990 | |||||
Mean difference indicates subtraction between values for cases and controls; negative values indicate cases having smaller values than controls.
P-value was computed by Dunnett test for multiple comparisons between cases and controls for individual clinics. Significant P values expressed in bold.
Nutritional status of NSD patients: Comparison of mean index of nutrition of patients with and without psychiatric disorders
| Variable | Psychiatry ( | Medicine ( | Dermatology ( | Ayurved ( | TOTAL ( | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean diff | Mean diff | Mean diff | Mean diff | Mean diff | ||||||
| Current major depressive episode | 0.05 | 0.9137 | 0.75 | 0.2171 | 0.61 | 0.3593 | 1.47 | 0.1390 | 0.36 | 0.2712 |
| CMDE with melancholic features | -0.01 | 0.9909 | 0.60 | 0.5250 | 0.70 | 0.5616 | 1.00 | 0.6698 | 0.30 | 0.5705 |
| Past major depressive episode | -0.64 | 0.2245 | -0.79 | 0.4393 | -1.55 | 0.1177 | -0.02 | 0.9844 | -1.07 | |
| Dysthymic disorder | -0.50 | 0.4062 | 0.06 | 0.9541 | -1.08 | 0.2153 | 2.02 | 0.3883 | -0.64 | 0.3269 |
| Minor depressive disorder | -3.15 | 0.1116 | -1.53 | -1.61 | 0.4943 | 0.59 | 0.4691 | -0.40 | 0.3970 | |
| Panic disorder | -0.34 | 0.6011 | 0.06 | 0.9541 | 1.47 | 0.2853 | - | - | -0.04 | 0.9497 |
| Social phobia | -1.39 | -0.12 | 0.8990 | -0.65 | 0.4838 | 2.09 | 0.1253 | -0.59 | 0.2167 | |
| Specific phobia | -0.75 | 0.2837 | -0.66 | 0.3529 | 0.87 | 0.4219 | 1.54 | 0.3571 | -0.03 | 0.9464 |
| Generalized anxiety disorder | -0.24 | 0.7232 | 0.07 | 0.8925 | 0.09 | 0.9155 | 2.16 | 0.64 | 0.0769 | |
| Anxiety disorder NOS | -0.40 | 0.5901 | -0.56 | 0.4336 | -0.73 | 0.2441 | -0.88 | 0.2182 | -0.79 | |
| Pain disorder | -0.22 | 0.7003 | 0.69 | 0.1641 | -0.42 | 0.6159 | 0.11 | 0.8954 | 0.47 | 0.1511 |
| Undifferentiated somatoform disorder | -0.29 | 0.5955 | -1.54 | -1.02 | 0.0612 | -0.11 | 0.8618 | -0.97 | ||
| Adjustment disorder | -0.12 | 0.8721 | 0.85 | 0.1000 | 0.79 | 0.2835 | -0.39 | 0.6342 | 0.75 | |
Notes: Negative value indicates higher mean index of nutrition for diagnosed patients Positive value indicates lower mean index of nutrition for diagnosed patients P value is based on t-test comparing the difference between means of indices of patients with and without a disorder. Significant P values expressed in bold.
Psychiatric diagnoses of patients with CS-FAW disorders (%)
| Diagnosis | Psychiatry ( | Medicine ( | Dermatology ( | Ayurved ( | Total ( | |
|---|---|---|---|---|---|---|
| Depressive disorders | 86.7 | 48.0 | 47.1 | 41.9 | 55.4 | <0.001 |
| Current major depression | 65.1 | 26.5 | 31.8 | 20.9 | 35.5 | |
| Past major depression | 26.5 | 6.1 | 9.4 | 9.3 | 12.5 | |
| Dysthymic disorder | 16.9 | 6.1 | 11.8 | 4.7 | 9.7 | |
| Minor depressive disorder | 1.2 | 18.4 | 3.5 | 14.0 | 9.7 | |
| Anxiety disorders | 81.9 | 77.6 | 75.3 | 57.0 | 73.0 | 0.001 |
| Panic disorder | 13.3 | 7.1 | 4.7 | 0.0 | 6.3 | |
| Panic disorder with agoraphobia | 6.0 | 4.1 | 1.2 | 0.0 | 2.8 | - |
| Agoraphobia without panic | 4.8 | 7.1 | 4.7 | 3.5 | 5.1 | - |
| Obsessive compulsive disorder | 2.4 | 0.0 | 2.4 | 0.0 | 1.1 | - |
| Social phobia | 12.0 | 6.1 | 8.2 | 5.8 | 8.0 | 0.408 |
| Specific phobia | 10.8 | 13.3 | 7.1 | 3.5 | 8.8 | 0.102 |
| Post-traumatic stress disorder | 4.8 | 2.0 | 1.2 | 0.0 | 2.0 | - |
| Generalized anxiety disorder | 12.0 | 25.5 | 11.8 | 14.0 | 16.2 | |
| Anxiety disorder NOS | 10.8 | 11.2 | 28.2 | 26.7 | 19.0 | |
| Mixed anxiety depression | 4.8 | 1.0 | 5.9 | 3.5 | 3.7 | 0.331 |
| Somatoform disorders | 51.8 | 62.2 | 64.7 | 66.3 | 61.4 | 0.212 |
| Somatization disorder | 4.8 | 3.1 | 1.2 | 0.0 | 2.3 | - |
| Pain disorder | 20.5 | 29.6 | 12.9 | 12.8 | 19.3 | |
| Undifferentiated somatoform disordera | 21.7 | 23.5 | 45.9 | 51.2 | 35.2 | |
| Hypochondriasis | 3.6 | 6.1 | 4.7 | 1.2 | 4.0 | - |
| Body dysmorphic disorder | 1.2 | 0.0 | 0.0 | 1.2 | 0.6 | - |
| Adjustment disorders | 9.6 | 25.5 | 15.3 | 15.1 | 16.8 | 0.131 |
| No diagnosis | 4.8 | 7.1 | 5.9 | 8.1 | 6.5 | 0.830 |
aDiagnosis based on symptoms other than fatigue and weakness. - : Not calculable. Significant P values expressed in bold.
Figure 1Distribution of mean SCL 90+ subscale scores